REGISTER NOW

We are currently in the center of a metabolic revolution where cutting edge science and tech meet consumer driven innovation. With infinite knowledge at consumers’ fingertips, brands need to be prepared to focus on their personal needs, perceptions and behaviors. Case in point, the exponential use of glucose control devices, like Continuous Glucose Monitors. Thanks to these devices, consumers are increasingly aware that our body’s capacity to maintain a balanced glucose control is constantly being challenged by our modern lifestyle. 

To address this concern, Rousselot developed Nextida GC, a specific collagen peptide composition that targets the glucose spike after a meal, as shown in a first clinical study.

Participate in this webinar to uncover:

REGISTER NOW

Speakers:

Janne Prawitt, Sicientific Director Health & Nutrition, Rousselot

Trained as a nutritional scientist Dr Janne Prawitt has spent 10 years in academic research in Germany and France in the field of metabolic diseases (such as obesity and diabetes). Janne joined Rousselot in 2013 where she is responsible for the science portfolio that focuses on the health benefits of Rousselot’s Health & Nutrition collagen products.

Mariëtte Abrahams, PhD, CEO & Founder of Qina, Qina

Mariëtte Abrahams PhD MBA RD is the CEO and Founder of Qina, a nutrition innovation consultancy and market intelligence platform focused on Personalized nutrition and prevention based in Portugal. Mariette has worked in clinical and medical nutrition industry for over 20 years. She leverages her combined expertise in nutrition, business and research to help businesses create the next generation of nutrition solutions at the intersection of health, technology and nutrition. She is a regular international speaker, is frequently quoted in the media, and is also published researcher in the area of Personalized nutrition.